Implantable cardioverter defibrillators in the prevention of sudden cardiac death


Cite item

Full Text

Abstract

The article highlights the role of implantable cardioverter defibrillators (ICDs) in the primary and secondary prevention of sudden cardiac death. It considers the results of multicenter studies comparing the efficacy of antiarrhythmic drugs and implantable devices in the primary and secondary prevention of sudden cardiac death, including that in patients with nonischemic cardiomyopathy and discusses quality of life in patients with ICDs.

About the authors

L A Bockeria

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

N M Neminushchiy

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

S I Mikhaylichenko

ФКГУ «ГВКГ им. Н.Н. Бурденко» МО РФ

Москва, Россия

S A Novichkov

ФКГУ «ГВКГ им. Н.Н. Бурденко» МО РФ

Москва, Россия

E E Achkasov

ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

References

  1. Mendis SPP, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization, 2011. ISBN 978-92-4-156437-3
  2. Машковский Е.В., Ачкасов Е.Е., Богова О.Т., Винничук Д.О. Влияние регулярных физических нагрузок на морфофункциональное состояние сердечно-сосудистой системы у действующих спортсменов и ветеранов спорта. Спортивная медицина: наука и практика. 2014;1:22-31. https://doi.org/10.17238
  3. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal 2015;36:2793-2867. https://doi.org/10.1093/eurheartj/ehv316
  4. Голухова Е.З., Громова О.И., Мерзляков В.Ю., Шумков К.В., Бокерия Л.А. Турбулентность ритма сердца и мозговой натрийуретический пептид как предикторы жизнеугрожающих аритмий у больных ишемической болезнью сердца. Креативная кардиология. 2013;2:62-77.
  5. Bayes de Luna A, Comel P, Leclercq JF, Bayes de Luna. A Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. American Heart Journal. 1989;117:151-159. https://doi.org/10.1016/0002-8703(89)90670-4
  6. Внезапная сердечная смерть. Рекомендации Европейского кардиологического общества. Под ред. Н.А. Мазура. М.: Медпрактика-М, 2003.
  7. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time dependence of risk. Circulation. 1992;85:12-20.
  8. Panidis IP, Morganroth J. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983;2(5):798-805. https://doi.org/10.1016/s0735-1097(83)80225-3
  9. Zheng ZJ, Croft JB, Giles W. H et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158-2163. https://doi.org/10.1161/hc4301.098254
  10. Mikhaylichenko SI, Gorbunov VV, Bogaticov EV, Mikhaylichenko MI. Sudden cardiac death protocol analyses of postmortem autopsies. Journal of Interventional cardiac electrophysiology 2015;42:173-326.
  11. Priori SG, Aliot E. Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations. Eur Heart J. 2001;22:1374-1450. https://doi.org/10.1053/euhj.2001.2824
  12. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:1064-1108. https://doi.org/10.1093/eurheartj/ehl199
  13. Ачкасов Е.Е., Пузин С.Н., Добровольский О.Б., Богова О.Т., Лазарева И.А., Пятенко В.В., Штефан О.С. Внезапная смерть молодых спортсменов (обзор зарубежной литературы). Спортивная медицина: наука и практика. 2013;3:85-92. https://doi.org/10.17238
  14. Бокерия О.Л., Ахобеков А.А. Внезапная сердечная смерть: механизмы возникновения и стратификация риска. Анналы аритмологии. 2012;3:5-13.
  15. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kaab S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J 2014; 35:1642-1651. https://doi.org/10.1093/eurheartj/ehu176
  16. Borne RT, Varosy PD, Masoudi FA. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches. JAMA Intern Med. 2013;173(10):859-865. https://doi.org/10.1001/jamainternmed.2013.428
  17. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303(6):322-324. https://doi.org/10.1016/s0196-0644(80)80503-8
  18. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883 https://doi.org/10.1056/nejmoa013474
  19. Kadish A, Dyer A, Daubert JP, et al; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350(21):2151-2158. https://doi.org/10.1056/nejmoa033088
  20. Ревишвили А.Ш. Всероссийское научное общество специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции (ВНОА). Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. 2013.
  21. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted Defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New Engl J Med 1996;335:1933-1940. https://doi.org/10.1056/nejm199612263352601
  22. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. Randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New Engl J Med 1999;341:1882-90. https://doi.org/10.1056/nejm199912163412503
  23. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. New Engl J Med 1997;337:1569-1575. https://doi.org/10.1056/nejm199711273372201
  24. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New Engl J Med 2005;352:225-237. https://doi.org/10.1056/nejm200505193522029
  25. Sharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN et al. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial. J Interv Card Electrophysiol 2007;19:157-164. https://doi.org/10.1007/s10840-007-9151-8
  26. Hoffa M, Ludwig C. Einige neue Versuche uber Herbewegung. Z Ration Med. 1850;9:107.
  27. Mirowski M, Mower MM, Staewen WS, et al. Standby automatic defibrillator: An approach to prevention of sudden coronary death. Arch Intern Med. 1970;126:158-161. https://doi.org/10.1001/archinte.1970.00310070160014
  28. Mirowski M, Mower M, Staewen W et al. The Development of the transvenous automatic defibrillator. Ibid. 1972;129:773-779. https://doi.org/10.1001/archinte.129.5.773
  29. Mower M, Reid P, Watkins L et al. Automatic Implantableт Cardioverter_Defibrillator: Structural characteristics. Pacing Clin Electrophysiol. 1984;7:1345-1350. https://doi.org/10.1111/j.1540-8159.1984.tb05704.x
  30. Kastor JA. Michel Mirowski and the Automatic Implantable Defibrillator. American Journal of Cardiology 1989;63:977-982. https://doi.org/10.1016/0002-9149(89)90152-5
  31. Курдгелия Т.М., Кислицина О.Н., Базарсадаева Т.С. Внезапная сердечная смерть: эпидемиология, факторы риска и профилактика. Бюллетень медицинских Интернет-конференций. 2014;4(3):221-227. ID: 2014-03-4109-R-3264
  32. Бокерия Л.А., Ревишвили А.Ш., Неминущий Н.М., Ломидзе Н.Н. Имплантируемые кардивертеры-дефибрилляторы в лечении аритмий и профилактике внезапной смерти. Сибирский медицинский журнал.2010;25(2):Выпуск 2:13-19.
  33. Connolly SJ, Gent M, Roberts RS et al. Canadian Implantable Defibrillation Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302. https://doi.org/10.1161/01.cir.101.11.1297
  34. AVID Investigators. Antiarrhythmic Versus Implantable Defibrillators (AVID); rationale, design, and methods. Am J Cardiol. 1995;75:470-475. https://doi.org/10.1016/s0002-9149(99)80583-9
  35. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;91:2195-2203. https://doi.org/10.1161/01.cir.91.8.2195
  36. Karl-Heinz Kuck, Riccardo Cappato, Jürgen Siebels and Rudolf Rüppel. Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest The Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754. https://doi.org/10.1161/01.cir.102.7.748
  37. Beat Schaer, Michael Kühne, Tobias Reichlin, Stefan Osswald, Christian Sticherling. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. https://doi.org/10.1093/europace/euv188 227-231
  38. Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62(18):1674-1679. https://doi.org/10.1016/j.jacc.2013.04.083
  39. Zecchin M., Sinagra G. Primary prevention of sudden death in dilated cardiomyopathy. Italian Heart J. 2004;5(suppl.1):81S-82S.
  40. Lars Køber, Jens J. Thune, Jens C Nielsen, Jens Haarbo, Lars Videbæk, Eva Korup, Gunnar Jensen, Per Hildebrandt, Flemming H Steffensen, Niels E. Bruun, Hans Eiskjær, Axel Brandes, Anna M Thøgersen, Finn Gustafsson, Kenneth Egstrup, Regitze Videbæk, Christian Hassager, Jesper H Svendsen, Dan E Høfsten, Christian Torp-Pedersen, and Steen Pehrson, D.M.Sc. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 2016;375:1221-1230. https://doi.org/10.1056/NEJMoa1608029
  41. Akshay S Desai, MPH; James C Fang, William H Maisel, MPH et al, Kenneth L Baughman. Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy. JAMA. 2004;292(23):2874-2879. https://doi.org/10.1001/jama.292.23.2874
  42. Sacher F., Tedrow U.B., Field M.E. et.al. Ventricular tachycardia ablation: evoluation of patient and procedure over 8 years. Circ Arrhytmic Electrophysiol. 2008;1:152-161. https://doi.org/10.1161/circep.108.769471
  43. Lampert R., Wang Y., Curtis J.P. Variation among hospitals in selection of higher-cost, higher-tech, implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) implantable cardioverter/defibrillators (ICD) registry. Am Heart J. 2013;165:1015-1023 (e1012). https://doi.org/10.1016/j.ahj.2012.12.003
  44. Myerburg RJ, Junttila M Juhani. Sudden Cardiac Death Caused by Coronary Heart Disease. Circulation. 2012;125:1043-1052. https://doi.org/10.1161/circulationaha.111.023846
  45. Poole JE, Johnson GW, Hellkamp AS et al. Prognostic Impotance of defibrillator shocks in patient with heart failure. N Engl J Med. 2008;359:1009-1017. https://doi.org/10.1056/nejmoa071098
  46. An Y, Ando K, Soga Y, Nomura A, Nagashima M, Hayashi K, Makihara Y, Fukunaga M, Hiroshima KI, Nobuyoshi M, Goya M. Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria. J Arrhythm. 2017; 33(1):17-22. https://doi.org/10.1016/j.joa.2016.01.012
  47. Бокерия Л.А., Ревишвили А.Ш., Неминущий Н.М. Внезапная сердечная смерть. М.: ГЭОТАР-Медиа, 2013.
  48. Ачкасов Е.Е., Пузин С.Н., Богова О.Т., Лисицкий Д.А., Таламбум Е.А., Руненко С.Д., Красавина Т.В., Сиденков А.Ю., Седерхольм Л.А. Редкое клиническое наблюдение длительного занятия спортом с постоянным электрокардиостимулятором. Спортивная медицина: наука и практика. 2013;1:23-26. https://doi.org/10.17238

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies